コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
5 t lymphangiogenic factor, is up-regulated in endometriotic cells and contributes to increased lymphan
11 clear atypia in the epithelial lining of all endometriotic cysts, histologically corresponding to aty
12 ning of 42 and 50% of peritoneal and ovarian endometriotic cysts, respectively, which were histologic
16 NF-alpha-induced signaling pathways in human endometriotic epithelial cells results in decreased expr
17 n of endometrial epithelial, endothelial and endometriotic epithelial cells with IL-33 led to the pro
23 ecrease resistance to invasion by cancer and endometriotic foci in other estrogen-responsive tissues.
25 NF-alpha-induced expression of all the above endometriotic genes in 12Z endometriotic epithelial cell
26 dy early angiogenesis in vivo and to monitor endometriotic growth and the efficacy of systemic antian
28 is, we now report that Icon largely destroys endometriotic implants by vascular disruption without ap
29 evealed five patients with surgically proved endometriotic implants in the ileum at enteroclysis (thr
32 le-contrast barium enema studies, associated endometriotic implants were found in the rectosigmoid co
33 hat host-derived TGFB1 deficiency suppresses endometriotic lesion development and provides proof of p
34 tigated the physiologic function of TGFB1 in endometriotic lesion development, using Tgfb1-null mutan
35 ed to the peritoneal environment early after endometriotic lesion establishment and remain present in
36 hese results suggest that TSLP modulates the endometriotic lesion microenvironment and promotes a Th2
37 Cs, HUVECs, and hESCs) representative of the endometriotic lesion microenvironment increased cytokine
39 ly is one of the fundamental requirements of endometriotic lesion survival in the peritoneal cavity.
40 44-3p/miR-451a cluster is expressed in human endometriotic lesion tissue, the level of expression cor
43 creased lymphatic vessels development in the endometriotic lesion, enlarged retroperitoneal lymph nod
44 ells are a disease-inducing component of the endometriotic lesion, we explored the response of 12Z im
46 y proved endometrioma and no associated deep endometriotic lesions and 317 healthy subjects for a cas
47 ential expression of IL-17A in human ectopic endometriotic lesions and matched eutopic endometrium fr
49 898 will prevent neovascularization of human endometriotic lesions and that ABT-898 treatment will no
50 trate that neutrophils reside within patient endometriotic lesions and that patient lesions possess a
51 functional cytokine that is abundant in both endometriotic lesions and the peritoneal fluid in women
52 The oxidative stress conditions found within endometriotic lesions are likely to contribute to the tr
53 positive endothelial cells incorporated into endometriotic lesions but not eutopic endometrium, as re
55 that RNABPs TTP and HuR are dysregulated in endometriotic lesions compared to matched eutopic patien
56 ession was elevated in the stroma of patient endometriotic lesions compared with control endometrial
57 ression levels were higher in macrophages of endometriotic lesions compared with control endometrial
61 m of affected women and secreted products of endometriotic lesions have given insight into the pathog
65 ese findings indicate that vasculogenesis in endometriotic lesions is dependent on estrogen, which ad
67 e the first evidence, to our knowledge, that endometriotic lesions produce IL-17A and that the remova
69 EPHA2 and EPHA4 expressions are increased in endometriotic lesions relative to normal eutopic endomet
71 s) to test our hypothesis that the growth of endometriotic lesions results in alterations in immune a
73 ouse model of endometriosis in which ectopic endometriotic lesions were deficient for both of these m
75 ere higher, but numbers of recruited EPCs in endometriotic lesions were significantly lower when comp
78 the loss of FKBP52 encourages the growth of endometriotic lesions with increased inflammation, cell
79 ABT-898 inhibits neovascularization of human endometriotic lesions without affecting mouse fecundity.
80 ression between patient eutopic endometrium, endometriotic lesions, and control endometrial samples.
81 romoting factor markedly expressed in active endometriotic lesions, and estradiol (E(2)) in ectopic e
82 red well with the location of the transgenic endometriotic lesions, and lesion size correlated with t
83 ssues are frequently being used to represent endometriotic lesions, despite the unequivocal differenc
84 olute bulk data from endometrial cancers and endometriotic lesions, illuminating the cell types domin
85 and platelets in close contact infiltrating endometriotic lesions, suggesting potential cell-cell in
86 nagement, and many aspects of the biology of endometriotic lesions, the pathophysiological mechanisms
87 e euthanized to assess neovascularization of endometriotic lesions, using CD31(+) immunofluorescence.
88 bition of COX-2 suppresses vasculogenesis in endometriotic lesions, which may contribute to an impair
101 P-TFII, VEGF-C, and lymphangiogenesis in the endometriotic microenvironment, which opens up new horiz
104 with surgically induced endometriosis and in endometriotic stromal cells biopsied from patients with
105 eted vimentin-positive poorly differentiated endometriotic stromal tissue and infiltrating macrophage
106 ons positively correlated with the amount of endometriotic tissue and peaked 1 to 4 days after induct
108 lytic isoform is highly elevated both in the endometriotic tissue of mice with surgically induced end
109 on, survival, and growth of endometrium-like/endometriotic tissue outside the uterine cavity, causing
111 thereby increasing the invasion activity of endometriotic tissues for establishment of ectopic lesio
112 ls, enhanced ERbeta activity was detected in endometriotic tissues, and the inhibition of enhanced ER